Philip J. Vickers is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 29,722 shares of RVNC, which is worth approximately $76,385. The most recent transaction as insider was on May 04, 2022, when has been sold 6,059 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.7K
0% 3M change
0% 12M change
Total Value Held $76,385

Philip J. Vickers Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 04 2022
BUY
Grant, award, or other acquisition
-
6,059 Added 16.93%
29,722 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
4,013 Added 14.5%
23,663 Common Stock

Also insider at

AVRO
AVROBIO, Inc. Healthcare
PJV

Philip J. Vickers

Director
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC